Trial Profile
Phase I/II pharmacokinetic study of oral hydroxyprogesterone caproate [LPCN 1107] in healthy women
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 29 May 2014
Price :
$35
*
At a glance
- Drugs Hydroxyprogesterone (Primary)
- Indications Preterm labour
- Focus Pharmacokinetics
- 29 May 2014 New trial record
- 13 May 2014 This trial has completed enrolment, according to a Lipocine media release. Results are expected to be released in the second quarter of 2014.